Quarterly report [Sections 13 or 15(d)]

PROPERTY AND EQUIPMENT, NET

v3.25.2
PROPERTY AND EQUIPMENT, NET
6 Months Ended
Jun. 30, 2025
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT, NET

NOTE 4 – PROPERTY AND EQUIPMENT, NET

 

Property and equipment are stated at cost and depreciated or amortized using the straight-line method based on useful lives as follows (in thousands):

 

    Useful lives (years)   June 30, 2025     December 31, 2024  
                 
Laboratory equipment   5   $ 9,598     $ 8,868  
Furniture, software and office equipment   3 to 5     2,236       1,113  
Leasehold improvements   Shorter of remaining lease term or useful life     8,913       8,805  
Construction-in-progress         4,800       624  
Subtotal         25,547       19,410  
Less: accumulated depreciation         (16,058 )     (14,980 )
Total property and equipment, net       $ 9,489     $ 4,430  

 

Construction-in-progress relates to leasehold improvements for the Company’s new office space as well as for conversion of existing office space into additional manufacturing space to increase ZEVASKYN™ manufacturing capacity.

 

Depreciation and amortization on property and equipment was $0.6 million and $0.5 million for the three months ended June 30, 2025 and 2024, respectively and $1.1 million and $1.0 million for the six months ended June 30, 2025 and 2024, respectively. The Company capitalized into inventory $0.1 million relating to depreciation associated with manufacturing equipment and production facilities for the three and six months ended June 30, 2025. The capitalized costs associated are added to inventory and will be expensed through cost of sales product in the condensed consolidated statement of operations and comprehensive income (loss) upon our first commercial sale of ZEVASKYN™